Written and medically reviewed by Dorcas Morak, PharmDOn October 20, 2022, the pharmaceutical company Sanofi announced that it would be discontinuing the sales of Adlyxin (lixisenatide) in the United States. Adlyxin is a medication used for the treatment of type 2 diabetes, and it was first approved by the US Food and Drug Administration (FDA) in 2016.
This news comes as a surprise to many patients who rely on Adlyxin to manage their diabetes, as well as healthcare providers who prescribe the medication. According to Sanofi, the decision to discontinue Adlyxin was based on several factors, including the availability of alternative treatments for type 2 diabetes and the overall financial performance of the drug.
Sanofi stated that patients currently taking Adlyxin should speak to their healthcare provider about switching to an alternative treatment. In addition, the company has assured patients that it will continue to provide support and resources during the transition period.
For patients who are currently taking Adlyxin, it is important to note that abruptly stopping the medication can have negative effects on blood sugar control. Therefore, it is essential to work closely with a healthcare provider to gradually transition to a new treatment plan.
It is also important to note that discontinuation of Adlyxin in the United States does not affect its availability in other countries. Adlyxin will continue to be sold and prescribed in other countries where it is approved for use.
Overall, the discontinuation of Adlyxin in the United States highlights the need for continued research and development of new treatments for type 2 diabetes. It also underscores the importance of working closely with healthcare providers to develop individualized treatment plans that meet the unique needs of each patient.
Is there an alternative to Adlyxin?
There are many other anti-diabetes medications you may be prescribed. Examples include Bydureon (exenatide extended-release for subcutaneous [SC] injection), Byetta (exenatide for SC injection), Ozempic (semaglutide for SC injection), Rybelsus (semaglutide tablets), Trulicity (dulaglutide for SC injection), and Victoza (liraglutide for SC injection).
How can I save cost on my diabetes medications?
You can save up to 88% on your medications using an rxless discount coupon. With an rxless discount coupon, the cost of medications won’t be a barrier to maintaining your health and treating your condition.